Blood pressure management after reperfusion in living-donor renal transplantatio
Not Applicable
- Conditions
- Recipient of living-donor renal transplantation
- Registration Number
- JPRN-UMIN000034766
- Lead Sponsor
- Kyushu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
Not provided
Exclusion Criteria
Under 18 years old. Intraoperative massive bleeding (>2,000ml).
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Renal function in the first seven postoperative days was the primary outcomes in this study.
- Secondary Outcome Measures
Name Time Method rine output after reperfusion and postoperative course were investigated.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie post-reperfusion hypertension in living-donor renal transplantation?
How does blood pressure management after reperfusion compare to standard-of-care protocols in renal transplant recipients?
Are there specific biomarkers that predict optimal blood pressure control outcomes in living-donor kidney transplantation?
What adverse events are associated with aggressive blood pressure management post-renal reperfusion and how are they managed?
How do current antihypertensive drug classes impact graft survival in living-donor renal transplantation studies?